View Older Stories View More Recent Stories

Aug 11, 2025 06:57PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Aug 11, 2025 08:00AM SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
Aug 7, 2025 06:45AM NeueHealth Reports Second Quarter 2025 Results
Aug 5, 2025 08:30AM August Raises $7M to Deliver Configurable Legal AI to Midsize Firms
Aug 5, 2025 08:00AM NEA-Backed NG.CASH Announces the Close of $26.5M Series B
Jul 24, 2025 09:58AM Healthcare-Focused Secondaries Manager Revelation Partners Names Rob Rein as Principal and Courtney Munley and Vicky Valverde as Senior Associates
Jul 17, 2025 09:00AM Veza Simplifies Oracle Access Governance with Unified Access Visibility, Intelligence, and Least Privilege Management
Jul 16, 2025 07:59AM Firestorm Labs Announces $47 million Series A Funding to Accelerate Growth and Innovation in Defense Technology
Jul 1, 2025 08:00AM Tailor Expands Series A to $22M with Private-Public Support
Jun 26, 2025 07:07AM Foresight Raises $5.5M Seed Round to Bring Unified Data and AI to the Private Market
Jun 11, 2025 03:00AM SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines
Jun 5, 2025 10:00AM NEA Promotes Madison Faulkner and Mustafa Neemuchwala to Partner
Jun 4, 2025 09:25AM THE POINTS GUY NAMES LIZA LANDSMAN AS CEO
Jun 2, 2025 08:00AM SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
May 28, 2025 07:43PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 28, 2025 04:09PM ORIC Pharmaceuticals Inc. (ORIC) Announces $125 Million Private Placement at $6.50/sh
May 28, 2025 04:05PM ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
May 16, 2025 04:16PM Form SCHEDULE 13D/A Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
May 15, 2025 03:00AM AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
May 14, 2025 10:00AM Samaya AI Announces $43.5m in Funding Led by NEA, Launches New AI Agent for Financial Services
May 13, 2025 04:15PM Form SCHEDULE 13G/A Sagimet Biosciences Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 12, 2025 04:15PM Form SCHEDULE 13D/A Arcellx, Inc. Filed by: New Enterprise Associates 15, L.P.
May 8, 2025 06:22PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
May 8, 2025 06:45AM NeueHealth Reports First Quarter 2025 Results
May 7, 2025 08:04PM Form SCHEDULE 13D/A Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
May 5, 2025 07:05AM IONQ Inc (IONQ) Appoints Jordan Shapiro as President and General Manager, Quantum Networking
May 5, 2025 07:05AM IonQ Appoints Jordan Shapiro to President and General Manager, Quantum Networking
May 5, 2025 02:30AM Inventiva secures the €116 million second tranche of its structured financing of up to €348 million
May 2, 2025 09:00AM CHAOS Industries Raises $275 Million Series C to Advance Defense and National Security Technology Innovation
May 1, 2025 10:01AM AviadoBio Announces Completion of Second Cohort in Phase 1/2 ASPIRE-FTD Clinical Trial Studying AVB-101 for FTD-GRN
Apr 28, 2025 09:00AM Veza Raises $108 Million in Series D at $808 Million Valuation to Meet Global Demand for its Pioneering Identity Security Platform
Apr 23, 2025 08:00AM Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
Apr 22, 2025 11:55AM Aigen Launches Next Generation Element Robots for Weeding in Partnership with Bowles Farming Company
Apr 16, 2025 09:00AM Jeffrey Immelt, Former GE Chairman & CEO, Appointed to Automation Anywhere's Board of Directors
Apr 8, 2025 11:00AM NEA Welcomes Anna Golynskaya as Partner, Head of Capital Formation and LP Relations
Mar 31, 2025 08:45AM Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results
Mar 31, 2025 08:00AM Construct Capital Closes $300 Million Fund III to Transform Foundational Industries
Mar 28, 2025 04:14PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 26, 2025 06:44AM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 12:12PM Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
Mar 25, 2025 09:01AM Illumina (ILMN) Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Mar 25, 2025 09:00AM Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Mar 21, 2025 09:00AM Second Front Systems Appoints Drew Hoffman as President and Chief Legal Officer
Mar 20, 2025 07:55PM Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Mar 20, 2025 04:01PM Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights
Mar 20, 2025 06:45AM NeueHealth Reports Fourth Quarter and Full Year 2024 Results
Mar 18, 2025 05:04PM Form SCHEDULE 13D/A BuzzFeed, Inc. Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
Mar 10, 2025 07:01PM Form SCHEDULE 13D/A Senti Biosciences, Inc. Filed by: New Enterprise Associates 15, L.P.
Mar 6, 2025 08:00AM Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor
Mar 4, 2025 08:00AM Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board
View More Recent Stories View Older Stories